ModernMedicine Resource Center More Topics

Video

What is Rosacea?

realself.com interviews Dr. Robert A. Weiss, of Maryland Laser Skin & Vein, at the 2013 ASDS Annual Meeting in Chicago. Weiss discusses the cause, potential aggravators, and available treatments for rosacea.

Rosacea Resource Center

It's rosacea, not acneNearly half of rosacea patients thought they had acne before being diagnosed. Learn how to explain the difference between rosacea and acne to patients and help them get the care they need.
Rosacea’s psychological impactResearchers assess the impact of facial erythema on the subconscious perceptions and initial reactions of others and how these affect their resulting attitudes.
New study uncovers genetic links to rosacea
New study uncovers genetic links to rosaceaResearchers have identified gene variants that could lead to new treatment targets and a better understanding of rosacea.
Rosacea: Newer topical therapies are effective and well-tolerated
Rosacea: Newer topical therapies are effective and well-toleratedEmerging therapies for rosacea have a favorable side effect profile and address specific symptoms of the condition; brimonidine, for example, addresses background erythema while ivermectin addresses the papules and pustules.
FDA Approves Ivermectin 1% Cream for Rosacea
FDA Approves Ivermectin 1% Cream for RosaceaLead author and a Galderma consultant dermatologist Linda Stein Gold, M.D. writes to Dermatology Times that results from Soolantra (ivermectin) Cream, 1% were seen in clinical studies as early as week two, with continuous improvement in patients with inflammatory lesions of rosacea.
Ivermectin effective for rosaceaTopical ivermectin cream 1 percent has shown safety and statistically superior efficacy versus vehicle as early as week two of treatment in phase 3 trials.
Clues about rosacea pathogenesis spark treatment advances
Clues about rosacea pathogenesis spark treatment advancesAs researchers learn more about the pathogenesis of rosacea, they can better understand the benefits of certain medications and find opportunities for new therapies.
Topical ivermectin emerges as option for rosacea
Topical ivermectin emerges as option for rosaceaIn the search for rosacea treatments, topical ivermectin 1 percent cream met its safety endpoints in two pivotal trials that included a total of 910 actively treated subjects, Galderma announced at the 72nd Annual Meeting of the American Academy of Dermatology.
Study finds evidence for rosacea subtype progression
Study finds evidence for rosacea subtype progressionA study shows data to suggest there is evidence of subtype progression in rosacea, and that flushing is not a universal characteristic of patients with subtype 1 rosacea.
Research sheds light on pathophysiology of acne, rosacea
Research sheds light on pathophysiology of acne, rosaceaAlthough the symptoms of acne and rosacea are well established, clear and definitive etiologies of these conditions have largely been unknown. Recent research, however, has shed new light into the pathophysiology of these conditions, paving the way for more targeted therapies.